Cara Therapeutics | CARA - Loan Capital


Cara Therapeutics reported $0 in Loan Capital for its fiscal quarter ending in March of 2025.





Loan Capital Change Date
Acadia Pharmaceuticals USD 0 0 Mar/2025
Alterity Therapeutics Limited AUD 43.68K 59.53K Dec/2025
Cara Therapeutics USD 0 0 Mar/2025
Cassava Sciences USD 0 0 Dec/2024
Chugai Pharma JPY 4.53B 1.95B Dec/2024
Cipla INR 3.82B 840.2M Mar/2026
Clal Biotechnology ILS 25.96M 18.48M Dec/2023
Compugen USD 0 0 Dec/2024
CSL USD 10.42B 273M Dec/2025
Grifols EUR 9.95B 722.93M Dec/2025
Halozyme Therapeutics USD 1.94B 206.73M Mar/2026
J&J USD 37.53B 1.91B Mar/2026
Neurocrine Biosciences USD 169.5M 500K Mar/2023
Pacira USD 367.66M 4.53M Mar/2026
Pfizer USD 60.57B 1.08B Mar/2026
RedHill Biopharma USD 900K 710K Dec/2025
Supernus Pharmaceuticals USD 400.38M 21.13M Mar/2022
Vanda Pharmaceuticals USD 3.15M 3.15M Dec/2024